Dr. Russell Lebovitz is the co-founder and CEO of biotech diagnostics company Amprion. He worked also as a senior scientist and research physician, and served on the faculty of Baylor College of Medicine in Houston. The research has led to breakthroughs in finding the presence of early-state Parkinson’s Disease. in 10% of cases the disease is genetic, but brain injuries can also create the conditions for some brain proteins to begin to alter. This can begin about 20 years before actual symptoms begin to appear, things such as stiffness in movement, difficulty with what usually is simply natural; voice changes–hesitation, stuttering.; changes in posture, balance.

www.amprionme.com